𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of Hodgkin's disease in elderly patients

✍ Scribed by Jose Rodriguez Diaz-Pavon; Fernando Cabanillas; Alejandro Majlis; Frederick B. Hagemeister

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
556 KB
Volume
13
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis

The outcome of Hodgkin's disease in elderly patients is a subject of controversy. We analysed retrospectively 31 cases of patients older than 60 years that received treatment according to current protocols. We observed a CR rate of 87 per cent and survival of 58 per cent with a median follow-up of 58 months which is clearly better than most reported results in this age group. Although our population consists of only those entered on protocols it suggests that patients whose condition is adequate enough to allow them to receive standard therapy with a curative intent, have a similar outcome to that seen in younger patients.

πŸ“œ SIMILAR VOLUMES

Hodgkin disease in ataxia-telangiectasia
Hodgkin disease in ataxia-telangiectasia patients with poor outcomes
✍ Sandoval, Claudio ;Swift, Michael πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

## Abstract ## Background To determine the presenting clinicopathologic features and treatment outcomes of 11 ataxia‐telangiectasia (A‐T) patients with Hodgkin disease. ## Procedure We reviewed the charts of 412 A‐T patients to ascertain cases of Hodgkin disease. The data analyzed included date

Intracranial Hodgkin's disease in two pa
Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease
✍ Ashigbi, Michael Y.; Venkatraj, Usha; Agarwal, Veneeta; Bello, Jackie; Wiernik, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 2 views

Intracranial Hodgkin's disease is very rare and is often a terminal event. The case of a 33-year-old man who relapsed in the anterior pituitary gland without other evidence of disease 6 months after extended field radiation therapy for Stage IIA Hodgkin's disease is presented. He remains well with n